Corporate acquisitions and mergers Pharmaceutical company Bristol-Myers Squibb proposes the takeover of cancer drug company Celgene for US$95 billion, including debt, the biggest biopharma deal ever. Bristol-Myers to buy Celgene for $74 billion in largest biopharma deal © Reuters Sources: Reuters